|

Semaglutide (administered by PDS290 pen-injector) Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Prof. Dr. Martin Wabitsch1

Indications

  • Monogenic Obesity1
  • Weight Loss1

Other1 trial

Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.